HomeAI · summaries
Storia in 8 fonti
FDA Authorizes Lower Disease Risk Claim for Select Philip Morris Zyn Nicotine Pouches - Philip Morris Int
FDA authorizes Philip Morris' unit to market 20 ZYN nicotine pouches with reduced disease risk claims after scientific review.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
healio.com
FDA authorizes marketing of risk modification claim on Zyn nicotine pouches
The FDA has authorized marketing of a risk modification claim on 20 Zyn nicotine pouch products that were authorized for sale in the U.S. last year.According to an FDA press…
- ·
cnbc.com
FDA lets Philip Morris market Zyn nicotine pouches as less harmful than cigarettes
The Trump administration has expanded access to nicotine products despite concerns from public health critics about youth use and addiction.
